evolocumab(Repatha)
PCSK9 inhibitor (monoclonal antibody)
Pronunciation
/iːvəˈlɒkjʊmæb/
International Phonetic Alphabet (IPA). Say it aloud once — you will remember it forever.
At a glance
- Generic name
- evolocumab
- Brand names
- Repatha
- Therapeutic class
- PCSK9 inhibitor (monoclonal antibody)
- Mechanism (summary)
- <!-- AI-DRAFTED: 2026-06-24 -->
Clinical pearls
- Inject under the skin every 2 weeks (140 mg) or monthly (420 mg).
- Rotate injection sites.
- Refrigerate; let warm to room temp 30 min before injecting.
- May continue statin and other lipid drugs.
- ### NAPLEX practice notes
Sources
See how evolocumab appears in NAPLEX-style questions
PharmDHub Premium includes a full drug card, dosing, boxed warnings, drug-drug interactions, and practice questions built around this drug.